Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists

Neuropharmacology
Barbara BosierDidier M Lambert

Abstract

While numerous cannabinoid ligands were historically characterized using the tetrad test (hypomobility, catalepsy, hypothermia, analgesia), only few studies have extensively compared HU 210 and CP 55,940 which are nowadays classically used as reference agonists. Therefore, we herein re-examined the acute and the sustained changes in motor activities mediated by these two agonists in adult rats. As expected for cannabinoid agonists, exposure to either HU 210 or CP 55,940 induced a marked reduction in spontaneous locomotion. This reduction observed as early as 15 min after injection was correlated with the typical rearing and cataleptic responses, and was reversed by co-administration of the CB(1) cannabinoid receptor antagonist SR 141716A. Nevertheless, HU 210, but not CP 55,940, was found to induce persistent responses, lasting for at least 24h. Also suggesting the involvement of additional targets for HU 210, 10mg/kg SR 141716A failed to reverse the persistent HU 210-mediated decline in locomotion and rearing, while 1mg/kg was sufficient to completely abolish the behavioural responses measured 6h after the injection. Beside pharmacokinetic differences, these data therefore denote distinct pharmacodynamic profiles for HU 210 an...Continue Reading

References

Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·B R MartinS J Ward
Jul 28, 1999·European Journal of Pharmacology·F PetitetA Imperato
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Mar 7, 2003·European Journal of Pharmacology·Alaster H Y Lau, Sharron S M Chow
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
Oct 19, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sophie J GovaertsDidier M Lambert
Mar 8, 2005·Molecular Pharmacology·Somnath Mukhopadhyay, Allyn C Howlett
Dec 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jane E LaucknerKen Mackie
Jan 27, 2006·The Journal of Pharmacology and Experimental Therapeutics·Gautham K Rao, Norbert E Kaminski
Feb 4, 2006·Current Pharmaceutical Design·Murat Oz
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Sep 26, 2006·Pharmacology, Biochemistry, and Behavior·T U C JärbeA Makriyannis
Jan 9, 2007·Lancet·Raj S Padwal, Sumit R Majumdar
Jun 28, 2007·The Journal of Biological Chemistry·Sharon Anavi-GofferMary E Abood
Sep 4, 2007·Biochemical and Biophysical Research Communications·Saori OkaTakayuki Sugiura
Dec 29, 2007·European Journal of Pharmacology·Teodora GeorgievaEva Varga
Mar 25, 2009·Pharmacology·Reyhan DemirJörg Ahrens
Apr 8, 2010·Current Topics in Medicinal Chemistry·Christopher J FowlerAnders Bergh

❮ Previous
Next ❯

Citations

Sep 29, 2012·The Journal of Pharmacology and Experimental Therapeutics·Carol A ParonisJack Bergman
Feb 4, 2014·European Journal of Pharmacology·Lenka Hruba, Lance R McMahon
Jan 21, 2016·The Journal of Pharmacology and Experimental Therapeutics·Doodipala Samba Reddy, Victoria M Golub
Jan 13, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Elisabetta EspositoRita Cortesi
Sep 27, 2018·Journal of Psychopharmacology·Douglas L BoggsPatrick D Skosnik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.